Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $56.00.
SLP has been the subject of several recent research reports. Oppenheimer raised their target price on shares of Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a report on Thursday, June 13th. Craig Hallum reaffirmed a “buy” rating and set a $56.00 target price on shares of Simulations Plus in a report on Wednesday, July 3rd. KeyCorp assumed coverage on Simulations Plus in a report on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Thursday, September 12th. Finally, JMP Securities started coverage on shares of Simulations Plus in a research note on Tuesday, July 16th. They issued a “market perform” rating for the company.
View Our Latest Stock Analysis on SLP
Insider Activity at Simulations Plus
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. Wasatch Advisors LP grew its stake in shares of Simulations Plus by 36.5% in the first quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock worth $15,707,000 after acquiring an additional 102,135 shares in the last quarter. Congress Asset Management Co. MA increased its holdings in Simulations Plus by 34.6% during the 1st quarter. Congress Asset Management Co. MA now owns 171,490 shares of the technology company’s stock worth $7,057,000 after purchasing an additional 44,129 shares during the period. Public Employees Retirement System of Ohio acquired a new stake in Simulations Plus in the 1st quarter valued at about $1,082,000. Silvercrest Asset Management Group LLC purchased a new position in shares of Simulations Plus in the 1st quarter valued at about $4,717,000. Finally, Hennion & Walsh Asset Management Inc. grew its position in shares of Simulations Plus by 49.0% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 35,845 shares of the technology company’s stock worth $1,475,000 after buying an additional 11,794 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.
Simulations Plus Stock Performance
Shares of Simulations Plus stock opened at $32.05 on Tuesday. The company has a market capitalization of $641.26 million, a PE ratio of 66.77 and a beta of 0.70. The company has a 50-day simple moving average of $37.52 and a two-hundred day simple moving average of $42.90. Simulations Plus has a one year low of $31.75 and a one year high of $51.22.
Simulations Plus (NASDAQ:SLP – Get Free Report) last announced its earnings results on Tuesday, July 2nd. The technology company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.04. The company had revenue of $18.54 million during the quarter, compared to the consensus estimate of $17.92 million. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. Simulations Plus’s revenue was up 14.2% compared to the same quarter last year. During the same period last year, the firm earned $0.20 earnings per share. On average, equities analysts predict that Simulations Plus will post 0.51 earnings per share for the current fiscal year.
Simulations Plus Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, August 5th. Shareholders of record on Monday, July 29th were issued a $0.06 dividend. The ex-dividend date was Monday, July 29th. This represents a $0.24 annualized dividend and a yield of 0.75%. Simulations Plus’s payout ratio is 50.00%.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Stories
- Five stocks we like better than Simulations Plus
- How to Most Effectively Use the MarketBeat Earnings Screener
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Do ETFs Pay Dividends? What You Need to Know
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- How to Buy Cheap Stocks Step by Step
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.